Skip to content

A retrospective study of late effect and prognosis of concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer.

A retrospective study of late effect and prognosis of concurrent chemoradiotherapy (CCRT) for locally advanced cervical cancer. - A retrospective study of late effect and prognosis of concurrent chemoradiotherapy (CCRT)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000025274
Enrollment
750
Registered
2016-12-14
Start date
2015-01-01
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer

Interventions

None listed

Sponsors

GOTIC (Gynecologic Oncology Trial and Investigation Consortium of North Kanto)
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Cervical cancer Stage IB2, IIB, IIIB, and IVA and treated by CCRT. Treatment start is from January 2001 to December 2010.

Exclusion criteria

Exclusion criteria: CCRT for post operative treatment

Design outcomes

Primary

MeasureTime frame
The frequency of small intestinal obstruction, rectal hemmorrhage, and bladder hemmorrhage

Countries

Japan

Contacts

Public ContactAkira Kurosaki

GOTIC (Gynecologic Oncology Trial and Investigation Consortium of North Kanto) Department of Gynecologic Oncology

akirak@saitama-med.ac.jp049-292-9043

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026